TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026 - FirstWord Pharma

Comentar en el chat

1fuente

1país

1idioma

15:50detectada el 09/11 (21:50 UTC)

15:50última novedad, 09/11

1noticia

La publicó primero FirstWord Pharma (Filipinas) el 09/11 a las 15:50 (21:50 UTC).

15:5009/11, 21:50 UTC

FPFirstWord Pharma news.google.com PH EN Primera
TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026 - FirstWord Pharma

Datos de esta historia: JSON